Fresenius establishes venture fund of more than 200 million euros

Germany’s Fresenius (FWB: FRE) is further expanding its access to innovation networks through its own corporate venture capital fund.

Fresenius Ventures invests in founders, technologies, and business models from early financing rounds through to the growth stage. The newly established unit combines venture capital with medical, regulatory, and operational expertise and provides access to clinical, scientific, and academic networks.